Evidence-Based Approach to Non-Opioid Pain Management
Over-prescription of opioids after dental and other types of surgery fueled the opioid epidemic in the United States, leading to 46,802 overdose deaths in 2018.1 In dentistry, nearly 1 in 3 opioids (29.6%) were prescribed for pain that was expected to be mild and 29.3% of prescriptions exceeded the recommended dose, according to an analysis of 542,958 U.S. dental visits between 2011 and 2015 within the Truven Health MarketScan Research Databases.2 More than half of the visits (53%) were for oral and maxillofacial surgery.
Evidence-Based Pain Management
Using an evidence-based, multi-modal approach, The Center For Oral Surgery & Dental Implants cares for most surgical patients with non-opioid pain management. “We now have many non opioid alternatives for pain management both during and after surgical procedures, and patients and families of patients are happy to hear that they will not be at risk of opioid habituation” says Dr. Rosie Noordhoek, an oral surgeon at The Center For Oral Surgery & Dental Implants.
Dr. Noordhoek and the other oral and maxillofacial surgeons in our practice follow the evidence-based pain management guidelines, best practices and recommendations of the:
- American Dental Association (ADA)
- Centers for Disease Control and Prevention (CDC)
- Michigan Opioid Prescribing Engagement Network
- Michigan Prescription Drug & Opioid Abuse Commission.
We also comply with Michigan state regulations and complete continuing education in prescribing opioids and other controlled substances.
Long-Lasting Pain Control
The evidence-based, multi-modal approach at The Center For Oral Surgery & Dental Implants starts with planning for post-operative pain management. Oral surgeons screen patients for risky substance-use behaviors and provide counseling about the benefits and drawbacks of opioids.
Techniques for long-lasting pain control used during surgery include EXPAREL, Sockit Gel, and Ketorolac. EXPAREL (bupivacaine liposome injectable suspension) is a single-dose, local anesthetic infiltration that provides significant pain control for the first few post-operative days while reducing opioid use.3 4 5 Sockit Gel is an all-natural, FDA-approved treatment that accelerates healing of oral wounds. The NSAID Ketorolac is administered intravenously or intramuscularly and replaces the first few doses of oral NSAIDS.
Post-surgery, ibuprofen and/or acetaminophen are the first-line pain-management treatments for our patients. Effective non-medication measures include rest, heat, ice, stretching, good hygiene, hydration and mindfulness practices such as meditation.
Low-Dose, Short-Term Opioids
For breakthrough or severe pain, the oral surgeons at The Center For Oral Surgery & Dental Implants prescribe the lowest effective opioid dose for no more than seven days, as per the ADA and CDC recommendations and guidelines. They educate patients on tapering the opioids as their pain resolves and how to store, monitor and dispose of unused medication at home.
The center’s oral surgeons electronically report prescription of opioids on the Michigan Automated Prescription System, the state’s prescription drug monitoring program.
For more information about non-opioid pain management at the Center For Oral Surgery & Dental Implants, call 616-361-7327.
1 Wilson N, Kariisa M, Seth P, Smith H IV, Davis NL. Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018. MMWR Morb Mortal Wkly Rep.2020;69:290–297. DOI: external icon. Accessed 6/9/20.
2 Suda KD, Zhou J, Woman SA, et al. Overprescribing of Opioids to Adults by Dentists in the U.S., 2011–2015. Am J Preventive Med. 2020; 58(4): 473-486. Accessed 6/9/20.
3 Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. 2018;33(1):90-96. doi:10.1016/j.arth.2017.07.024.
4 Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54(12):1552-1559.
5 Data on File. 2857. Parsippany, NJ: Pacira Pharmaceuticals, Inc.; June 2017.
Comments are closed.